Literature DB >> 27385243

Ten-Year Trends In Treatment Services For Children With Attention Deficit Hyperactivity Disorder Enrolled In Medicaid.

Kimberly E Hoagwood1, Kelly Kelleher2, Bonnie T Zima3, James M Perrin4, Scott Bilder5, Stephen Crystal6.   

Abstract

Closing the gap between evidence-based clinical practice standards and their inclusion in routine practice continues to be a major goal of health policy reforms. This gap is especially large for the care of children with psychiatric disorders-especially those from low-income families, many of whom are insured through Medicaid. To address this gap, we analyzed trends over ten years (2001-10) from Medicaid claims data describing changes over time in medication, psychotherapy, and combined treatment services for children diagnosed with attention deficit hyperactivity disorder (ADHD). Over this time, more children received treatments that conformed to practice standards, including the use of combination treatments of medication and psychotherapy. Rates of combined treatment increased by 74 percent, rates of psychotherapy alone more than doubled, and rates of medication alone decreased by 18 percent. Rates of diagnoses without any reimbursed treatment decreased by 39 percent. These trends suggest increasing adherence to clinical practice standards by providers serving children with ADHD in the Medicaid population, although the quality of those services is unknown. Project HOPE—The People-to-People Health Foundation, Inc.

Entities:  

Keywords:  ADHD; Low Income; Medicaid; Treatment; Youth

Mesh:

Substances:

Year:  2016        PMID: 27385243      PMCID: PMC5549683          DOI: 10.1377/hlthaff.2015.1423

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  22 in total

1.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.

Authors: 
Journal:  Arch Gen Psychiatry       Date:  1999-12

2.  Quality of care for childhood attention-deficit/hyperactivity disorder in a managed care medicaid program.

Authors:  Bonnie T Zima; Regina Bussing; Lingqi Tang; Lily Zhang; Susan Ettner; Thomas R Belin; Kenneth B Wells
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-10-29       Impact factor: 8.829

3.  Are we on the right track? Examining the role of developmental behavioral pediatrics.

Authors:  Ruth E K Stein
Journal:  Pediatrics       Date:  2015-03-16       Impact factor: 7.124

4.  Poverty and mental health: how do low-income adults and children fare in psychotherapy?

Authors:  Catherine DeCarlo Santiago; Stacey Kaltman; Jeanne Miranda
Journal:  J Clin Psychol       Date:  2012-12-20

5.  Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings.

Authors:  R T Brown; W S Freeman; J M Perrin; M T Stein; R W Amler; H M Feldman; K Pierce; M L Wolraich
Journal:  Pediatrics       Date:  2001-03       Impact factor: 7.124

6.  Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007.

Authors:  Kandyce Larson; Shirley A Russ; Robert S Kahn; Neal Halfon
Journal:  Pediatrics       Date:  2011-02-07       Impact factor: 7.124

7.  Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder.

Authors: 
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

8.  Mapping evidence-based treatments for children and adolescents: application of the distillation and matching model to 615 treatments from 322 randomized trials.

Authors:  Bruce F Chorpita; Eric L Daleiden
Journal:  J Consult Clin Psychol       Date:  2009-06

9.  Facing reality and jumping the chasm.

Authors:  Leonard Bickman
Journal:  Adm Policy Ment Health       Date:  2013-01

10.  Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.

Authors:  Lily Hechtman; Howard Abikoff; Rachel G Klein; Gabrielle Weiss; Chara Respitz; Joan Kouri; Carol Blum; Brian Greenfield; Joy Etcovitch; Karen Fleiss; Simcha Pollack
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-07       Impact factor: 8.829

View more
  8 in total

1.  A National Description of Treatment among United States Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.

Authors:  Melissa L Danielson; Susanna N Visser; Andrea Chronis-Tuscano; George J DuPaul
Journal:  J Pediatr       Date:  2017-11-10       Impact factor: 4.406

2.  Health Care Utilization and Spending for Children With Mental Health Conditions in Medicaid.

Authors:  Stephanie K Doupnik; Jonathan Rodean; James Feinstein; James C Gay; Julia Simmons; Jessica L Bettenhausen; Jessica L Markham; Matt Hall; Bonnie T Zima; Jay G Berry
Journal:  Acad Pediatr       Date:  2020-02-02       Impact factor: 3.107

3.  Off-label Prescribing Trends for ADHD Medications in Very Young Children.

Authors:  Shannon G Panther; Alice M Knotts; Tamara Odom-Maryon; Kenneth Daratha; Teri Woo; Tracy A Klein
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Nov-Dec

4.  State-to-State Variation in SSI Enrollment for Children With Mental Disabilities: An Administrative and Ethical Challenge.

Authors:  Kimberly E Hoagwood; Bonnie T Zima; Stephen L Buka; Amy Houtrow; Kelly J Kelleher
Journal:  Psychiatr Serv       Date:  2016-10-03       Impact factor: 3.084

5.  Racial-Ethnic Differences in Patterns of Discontinuous Medication Treatment Among Medicaid-Insured Youths With ADHD.

Authors:  Xu Ji; Benjamin G Druss; Cathy Lally; Janet R Cummings
Journal:  Psychiatr Serv       Date:  2017-12-01       Impact factor: 3.084

Review 6.  Review of barriers and interventions to promote treatment engagement for pediatric attention deficit hyperactivity disorder care.

Authors:  Raman Baweja; Cesar A Soutullo; James G Waxmonsky
Journal:  World J Psychiatry       Date:  2021-12-19

7.  Stepped Treatment for Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior: A Randomized, Controlled Trial of Adjunctive Risperidone, Divalproex Sodium, or Placebo After Stimulant Medication Optimization.

Authors:  Joseph C Blader; Steven R Pliszka; Vivian Kafantaris; Carmel A Foley; Gabrielle A Carlson; Judith A Crowell; Brigitte Y Bailey; Colin Sauder; W Burleson Daviss; Christa Sinha; Thomas L Matthews; David M Margulies
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2020-01-30       Impact factor: 8.829

8.  Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016.

Authors:  Brian J Piper; Christy L Ogden; Olapeju M Simoyan; Daniel Y Chung; James F Caggiano; Stephanie D Nichols; Kenneth L McCall
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.